SCM
NVAX icon

Shah Capital Management’s Novavax NVAX Stock Holding History

Shah Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$133M Sell
14,165,577
-679,520
-5% -$6.09M 25.36% 2
2026
Q1 		$121M Buy
14,845,097
+286,317
+2% +$2.6M 23.18% 2
2025
Q4 		$97.8M Buy
14,558,780
+2,747,000
+23% +$20.7M 18.87% 2
2025
Q3 		$102M Buy
11,811,780
+300,000
+3% +$2.33M 18.32% 2
2025
Q2 		$72.5M Buy
11,511,780
+379,934
+3% +$2.52M 14.11% 3
2025
Q1 		$71.4M Sell
11,131,846
-17,000
-0.2% -$141K 14.58% 2
2024
Q4 		$89.6M Buy
11,148,846
+1,333,305
+14% +$12.9M 18.08% 2
2024
Q3 		$124M Buy
9,815,541
+153,451
+2% +$1.98M 24.16% 2
2024
Q2 		$122M Buy
9,662,090
+1,544,263
+19% +$15.5M 26.46% 2
2024
Q1 		$38.8M Buy
8,117,827
+337,071
+4% +$1.56M 10.86% 3
2023
Q4 		$37.3M Buy
7,780,756
+1,450,000
+23% +$8.88M 9.57% 4
2023
Q3 		$45.8M Buy
6,330,756
+850,000
+16% +$6.79M 10.84% 4
2023
Q2 		$40.7M Buy
5,480,756
+1,229,680
+29% +$9.67M 10.35% 5
2023
Q1 		$29.5M Buy
4,251,076
+3,536,076
+495% +$32.5M 8.57% 5
2022
Q4 		$7.35M Buy
+715,000
New +$12.6M 1.75% 11

Other funds holding NVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Shah Capital Management's NVAX Position: Q2 2026 in Review

Shah Capital Management reduced its Novavax (NVAX) stake by 4.6% in Q2 2026, selling an estimated $6.09M and leaving 14,165,577 shares worth $133M. The position accounts for 25.36% of the portfolio, ranked #2.

Shah Capital Management first reported a position in NVAX in Q4 2022 and has held it in 15 quarters since. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Shah Capital Management held 14,165,577 shares of Novavax worth $133M as of Q2 2026.
  • Shah Capital Management sold 679,520 Novavax shares in Q2 2026, an estimated $6.09M.
  • Novavax made up 25.36% of Shah Capital Management's portfolio in Q2 2026, its #2 holding.
  • Shah Capital Management first reported a position in Novavax in Q4 2022 and has held it in 15 quarters since.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Shah Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.